| Literature DB >> 12781194 |
Stephen W Wright1, Anthony A Carlo, Dennis E Danley, David L Hageman, George A Karam, Mahmoud N Mansour, Lester D McClure, Jayvardhan Pandit, Gayle K Schulte, Judith L Treadway, Ing-Kae Wang, Paul H Bauer.
Abstract
3-(2-Carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid (MDL-29951), an antagonist of the glycine site of the NMDA receptor, has been found to be an allosteric inhibitor of the enzyme fructose 1,6-bisphosphatase. The compound binds at the AMP regulatory site by X-ray crystallography. This represents a new approach to inhibition of fructose 1,6-bisphosphatase and serves as a lead for further drug design.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12781194 DOI: 10.1016/s0960-894x(03)00310-x
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823